130.89USD-2.60%Mkt Cap: 163.09B USDP/E: 17.87Last update: 2026-06-01
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, D…
Industry Peers
Drug Manufacturers - GeneralIndicators:|
Key Statistics
Company
Market Cap163.09B USD
Enterprise Value179.18B USD
Revenue (TTM)29.74B USD
Gross Profit23.21B USD
Net Income (TTM)8.51B USD
Revenue/Share23.92 USD
Last Price130.89 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS3755581036
Valuation
P/E (Trailing)17.87
P/E (Forward)14.02
PEG2.14
EV/EBITDA12.16
EV/Revenue6.03
P/S5.61
P/B7.10
EPS (TTM)7.36
EPS (Forward)9.59
52W Range
104.4650% of range157.29
52W High157.29 USD
52W Low104.46 USD
Profitability
Gross Margin78.83%
Oper. Margin39.28%
EBITDA Margin49.56%
Profit Margin28.90%
ROE37.49%
ROA14.42%
Growth
Revenue Growth4.40%
Earnings Growth54.80%
Cash Flow & Leverage
Operating CF10.02B USD
CapEx (TTM)563.00M USD
FCF Margin26.68%
FCF Yield4.86%
Net Debt12.36B USD
Net Debt/EBITDA0.84
Balance Sheet
Debt/Equity1.10
Current Ratio1.97
Quick Ratio1.54
Book Value/Sh18.93 USD
Cash/Share7.907 USD
Dividends
Fwd Div Rate3.280 USD
Trail. Div Rate3.190 USD
Div. Yield2.41%
5Y Avg Yield3.65%
Payout Ratio43.40%
Ex-Div DateJun 15, 2026
Pay DateJun 29, 2026
Splits
Last Split2:1
Split DateJan 28, 2013
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)157.83 USD
Target Range122.00 USD – 180.00 USD
# Analysts29
Ownership
Shares Out.1.24B
Float1.24B
Insiders0.12%
Institutions92.17%
Short Interest
Short Ratio3.8d
Short % Float1.87%
Short % Out.1.86%
Shares Short23.14M
Short (prev mo.)22.75M
Technical
SMA 50135.24 (-3.2%)
SMA 200128.58 (+1.8%)
Beta0.33
S&P 52W Chg27.94%
Avg Vol (30d)5.54M
Avg Vol (10d)5.49M
Technical Indicators
RSI (14)52.0
MACD-0.2880
MACD Signal-0.9359
MACD Hist.+0.6479
BB Upper136.87 USD
BB Middle132.84 USD
BB Lower128.82 USD
BB Width6.06%
ATR (14)3.146 USD
Vol Ratio (20d)0.55x